Secondary Compound definition

Secondary Compound means a Compound in a PROSENSA Collaboration Program that meets the Candidate Selection Criteria but is not selected for progression to POC studies by the JSC as set forth in Section 2.5.
Sample 1Sample 2
Secondary Compound means any compound (other than the Compound) claimed in [***].
Sample 1Sample 2
Secondary Compound means (i) a PDE10 inhibitor or modulator, other than a Primary Compound, (a) for which Amgen during the Agreement Term has rights, whether by reason of its own conception of such inhibitor or modulator, or under agreement with a Third Party, (b) was identified or confirmed as a PDE10 inhibitor or modulator through the use of the Memory Screening Technology, and (c) subject to Section 7.3(a), with respect to which the initial IND for the inhibitor or modulator has not been filed within [*] after the Effective Date by Amgen or its Affiliate, or (ii) [*] or as identified by Memory on Schedule 1.60 attached hereto.
Sample 1

Examples of Secondary Compound in a sentence

  • If, after exercise of the Option with respect to a PROSENSA Collaboration Program, GSK determines, after good faith discussions with the JSC, but with GSK retaining final decision-making authority, that the Lead Compound, on the basis of reasonable, commercial or regulatory considerations, is not suitable for further development, GSK may elect to replace the Lead Compound with the Secondary Compound from such Program.

  • For clarity, PROSENSA shall have no obligations to develop, and will not be required to bear any Development costs with respect to, any Secondary Compound beyond Clinical Candidate Selection, or to any other Compound.

  • For the purposes of this Agreement, "AMGEN COMPOUND" means a PDE10 inhibitor or modulator, other than a Primary Compound or Secondary Compound, (a) for which Amgen during the Agreement Term has rights, whether by reason of its own conception of such inhibitor or modulator, or under agreement with a Third Party, and (b) was not identified or confirmed as a PDE10 inhibitor or modulator through the use of the Memory Screening Technology.

  • Using this Selected Assay, UNIVERSITY shall screen each Secondary Compound for activity in relation to the Selected Target and provide all data (including but not limited to the EC50 for each Secondary Compound) resulting therefrom (the "Secondary Results") to TELIK within [*] of UNIVERSITY's receipt of the Secondary Compounds.

  • Regardless of whether Millennium or Schering exercise their respective rights to either a Put or a Call pursuant to Section 7.2 or 7.3, respectively, Schering and Millennium will share equally the cost of capital equipment, including any related software and cost of installation and start-up for such equipment, charged by the Third Party Contractor, necessary to qualify the Secondary Compound Supplier.

  • These included: the Power Distribution Building (REWS), the Maintenance & Storage Buildings 1 & 2 (REWS), Storage Van & Equipment Pads (REWS), Road Repair (REWS), a Potable Water Tank (REWS), and a Secondary Compound Security Fence (REWS).


More Definitions of Secondary Compound

Secondary Compound means (i) a PDE10 inhibitor or modulator, other than a Primary Compound, (a) for which Amgen during the Agreement Term has rights, whether by reason of its own conception of such inhibitor or modulator, or under agreement with a Third Party, (b) was identified or confirmed as a PDE10 inhibitor or modulator through the use of the Memory Screening Technology, and (c) which neither Amgen nor its Affiliate has dosed in a human within [*] after the Effective Date, or (ii) [*] or as identified by Memory on Schedule 1.60 attached hereto.”
Sample 1

Related to Secondary Compound

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compound means [***].

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Compounds means any or all of the following chemicals, as the context requires:

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Exempt compound means the same as defined in Rule 2.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Competing Product means […***…].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Active Pharmaceutical Ingredient or “API” means the active pharmaceutical substance of the Drug in bulk form prior to incorporation into the Product.

  • Commercialized shall have corresponding meanings.